Summary

Overview
Global intrauterine pressure catheters market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
The global intrauterine pressure catheters market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. An intrauterine pressure catheter (IUPC), which measures the force of uterine contractions, is put into the amniotic sac during labor.
Utilizing a pressure transducer at the catheter's tip, intrauterine pressure catheters measure the amniotic space's pressure directly, providing a quantitative measurement of the contraction's force. Contraction is measured in mm Hg and graphically shown on the monitor following connection to the relevant cable.
Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fluid-filled catheters or Transducer-tipped Catheters and boost the global intrauterine pressure catheters market. The respective innovative products are may be utilized in people with different age groups.
Market Dynamics: Drivers & Restraints
Growing collaborations and expansion
Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for intrauterine pressure catheters owing to the rising pregnancies. Various collaborations, acquisitions and product launches with technological advancements among different countries will be a crucial factor driving the growth of the market.
On December 17, 2021, the Lower Kirby District of Pearland has been announced as the new headquarters for Millar, Inc., according to the leadership of the City of Pearland along with the Pearland Economic Development Corporation (PEDC). In order to transform ground-breaking technological advancements into life-saving medical inventions, Millar, Inc., an established developer and producer of pressure sensor-enabled products, collaborates with world authorities in manufacturing, healthcare, and technology.
Additionally on January 10, 2022, the FDA-cleared, remote pregnancy monitoring platform INVU which is prescription-initiated, by Nuvo is being marketed by Nuvo Group, a private company. Nuvo Group partnered with Unified Women's Healthcare, the largest, most diverse physician practice management company in the country that caters exclusively to women.
Furthermore, the rising utilization of novel technology and different types of intrauterine pressure catheters for the management purposes. Rising risks in pregnancies and increasing research for innovative management product development will be a major factor driving the growth of the intrauterine pressure catheters market.
Complications associated with intrauterine pressure catheters
Intrauterine pressure catheter insertion is a common technique carried regularly in labor and delivery units with minimal related problems. Numerous investigations have linked the application of intrauterine pressure catheters and its uncommon negative effects to maternal and newborn morbidity.
A uncommon reported consequence linked to the implantation of intrauterine pressure catheters is uterine perforation. Intrauterine pressure catheters should be inserted with care, and being aware of any potential consequences will help with an early diagnosis and the selection of the best course of action.
Segment Analysis
The global intrauterine pressure catheters market is segmented based on product type, end user and region.
Transducer-tipped Catheter segment accounted for approximately 73% of market share
A catheter tip pressure transducer is utilized for sensing the pressure in various sections of a living organism correctly and securely which comprises a pressure sensor positioned within the tip portion of a catheter. A pressure-sensitive diaphragm on which strain gauges are produced using the diffusion process is part of the pressure sensor.
The pressure sensor is attached but not firmly fastened to an insulated supporting element. Without being impacted by the thermal stresses that occur in the supporting element, the pressure sensor properly measures pressure. The uterine cavity is the intended location for this device. Many of the drawbacks of the conventional approach are eliminated with such a system.
According to the Journal of Reproductive Medicine publication, 2021, as safe as or safer than IUPCs already in use, Koala is just as functionally effective as or more so than IUPCs. The Koala also showed a number of benefits, such as a softer, shorter catheter tip that makes it easier to insert, a simpler, more compact design that makes it safer to insert and easier to operate, and precise transmission of signals to monitor.
Geographical Penetration
North America accounted for around 38% of market share in 2022
Due to the rising need for intrauterine pressure catheters in healthcare, manufacturers in North America have chances of increasing their operations. Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or medical device business establishment across the region are also contributing to the growth of intrauterine pressure catheters market share of this region.
The market in this area is growing as people become more aware of various novel innovative products such as fluid-filled catheters. The aforementioned elements attest to North America's hegemonic position in the world. An intrauterine pressure catheter is used to monitor 15–20% (600,000–800,000) of the 4 million deliveries that take place each year in the United States. This method gives the practitioner diagnostic data that is helpful for determining the pressures produced by the myometrium and monitoring the health of the fetus throughout labor and delivery.
North America continues to be a key player in the global intrauterine pressure catheters market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for intrauterine pressure catheters in the U.S. United States have been proactive in executing several initiatives or researches, stimulating intrauterine pressure catheters demand.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global intrauterine pressure catheters market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all over the world were disturbed by the pandemic's broad lockdowns and strict limitations that started in early 2020.
Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for intrauterine pressure catheters. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global intrauterine pressure catheters market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like transducer-tipped catheter.

Key Developments
• On March 22, 2023, in order to create a more inclusive pregnancy care encounter from the prenatal stage through delivery and labor, Royal Philips, an international pioneer in health technological devices, and Nuvo Group, a privately held corporation marketing INVU by Nuvo, a prescription-initiated, FDA-cleared, remote pregnancy tracking platform, have joined forces. Philips and Nuvo will work together to facilitate remote fetal monitoring pilot initiatives that increase access to and adherence to recommended care in outlying locations. The first program will be in a rural Colorado community.
• On August 16, 2022, the Australian Therapeutic Goods Administration (TGA) has given the Mikro-Cath Pressure Catheter manufacturer Millar, Inc. clearance to market it. The Mikro-Cath is a single-use pressure catheter designed for use in diagnostic and research procedures in medicine. For monitoring intra-compartmental, cardiovascular pressures and airway in people, the catheter is advised. The catheter is utilized as a short-term, restricted body contact minimally invasive device.
Competitive Landscape
The major global players in the market include Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Laborie, GE HealthCare, Cook, VYAIRE, Millar, Inc. and Clinical Innovations, LLC among others.
Why Purchase the Report?
• To visualize the global intrauterine pressure catheters market segmentation based on product type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of intrauterine pressure catheters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global intrauterine pressure catheters market report would provide approximately 53 tables, 46 figures and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents